Vaickus Louis J, Bouchard Jacqueline, Kim Jiyoun, Natarajan Sudha, Remick Daniel G
Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
J Asthma. 2012 Jun;49(5):510-21. doi: 10.3109/02770903.2012.678958. Epub 2012 Apr 30.
The aim of this study is to define the kinetics of the pulmonary inflammatory response in cockroach allergen (CRA) sensitized and challenged outbred mice.
Asthma-like pulmonary inflammation was induced with three pulmonary exposures to CRA, without the use of adjuvants. Mice were sacrificed at multiple time points and asthma-like pulmonary inflammation quantified.
Several pulmonary parameters showed a pronounced biphasic inflammatory response with an early stage (1.5 hours post challenge) and late stage (24 hours). The initial phase was characterized by the production of multiple inflammatory mediators, including CXC chemokines, and the recruitment of neutrophils to the lung. The number of pulmonary eosinophils decreased in the early phase but quickly rebounded. Both the early and late phases had increases in TNF production in addition to airways hyperreactivity. The model also demonstrated early production of mucin with clearance by 12 hours followed by new accumulation of mucin in the pulmonary epithelial cells. Eotaxins within the lung peaked at about 12 hours and the numbers of eosinophils in the lung remained constant throughout the 48 hours of the study.
The pulmonary inflammatory parameters in response to a clinically relevant allergen define a biphasic response. These data may be used to investigate the pathogenesis of the disease and develop targeted therapies for the distinct phases.
本研究旨在确定蟑螂变应原(CRA)致敏并激发的远交系小鼠肺部炎症反应的动力学。
通过三次肺部暴露于CRA诱导类似哮喘的肺部炎症,不使用佐剂。在多个时间点处死小鼠并对类似哮喘的肺部炎症进行量化。
几个肺部参数显示出明显的双相炎症反应,分为早期(激发后1.5小时)和晚期(24小时)。初始阶段的特征是多种炎症介质的产生,包括CXC趋化因子,以及中性粒细胞向肺部的募集。肺部嗜酸性粒细胞数量在早期减少但迅速反弹。早期和晚期除了气道高反应性外,肿瘤坏死因子(TNF)的产生均增加。该模型还显示早期产生粘蛋白,并在12小时内清除,随后肺部上皮细胞中粘蛋白重新积累。肺内嗜酸性粒细胞趋化因子在约12小时达到峰值,并且在研究的48小时内肺内嗜酸性粒细胞数量保持恒定。
对临床相关变应原的肺部炎症参数定义了一种双相反应。这些数据可用于研究疾病的发病机制,并为不同阶段开发靶向治疗方法。